City
Epaper

Iran produces drug to heal lung lesion of COVID-19 patients

By IANS | Updated: March 18, 2020 09:41 IST

Iranian researchers have discovered a drug combination to heal the lesions in the lungs of COVID-19 patients, IRNA news agency quoted an Iranian health official as saying.

Open in App

Tehran, March 18 Iranian researchers have discovered a drug combination to heal the lesions in the lungs of COVID-19 patients, IRNA news agency quoted an Iranian health official as saying.

Mostafa Qanei, head of the scientific committee to combat COVID-19, said the "complex" is the combination of three medicines which could reduce the period of hospitalisation of the patients, Xinhua reported.

"We have diagnosed the lung lesion, and this complex aims to heal the lesion," Qanei was quoted as saying.

 

He noted 40 per cent of the patients who received the medicine left the hospital four days earlier.

Iran's Ministry of Health and Medical Education on Tuesday announced that 16,169 people have been affected with the coronavirus, of whom 988 have died.

( With inputs from IANS )

Tags: Mostafa qaneiIrnaXinhua
Open in App

Related Stories

InternationalMajor UK Railway Stations Hit by Cyber Attack; Network Rail Suspends Wi-Fi Service

InternationalGreece braces for first summer heat wave

PoliticsSudan govt willing to work with all parties to end conflict

InternationalCyprus prepares for emergencies in face of approaching heat wave

PoliticsUkraine receives cluster munitions from US

स्वास्थ्य Realted Stories

HealthChemicals in food containers, medical equipment behind spike in heart disease deaths: Lancet

HealthWho’s Steering Indian Health Policy? COP11 Puts Foreign Interference in the Spotlight

HealthIsraeli researchers discovered stress in pregnancy affects baby's brain before birth

HealthJabalpur’s newborn gets life-saving heart treatment under Rashtriya Bal Swasthya Karyakram

HealthCovid-19 vaccines have no lasting impact on metabolic health: Study